Determination of clinical and demographic predictors of laboratory-confirmed influenza with subtype analysis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2334
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Determination of clinical and demographic predictors of laboratory-confirmed influenza with subtype analysis ; volume:12 ; number:1 ; day:7 ; month:6 ; year:2012 ; pages:1-11 ; date:12.2012
BMC infectious diseases ; 12, Heft 1 (7.6.2012), 1-11, 12.2012
- Urheber
-
Woolpert, Tabitha
- Beteiligte Personen und Organisationen
-
Brodine, Stephanie
Lemus, Hector
Waalen, Jill
Blair, Patrick
Faix, Dennis
SpringerLink (Online service)
- DOI
-
10.1186/1471-2334-12-129
- URN
-
urn:nbn:de:1111-201603032410
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:20 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Woolpert, Tabitha
- Brodine, Stephanie
- Lemus, Hector
- Waalen, Jill
- Blair, Patrick
- Faix, Dennis
- SpringerLink (Online service)
Ähnliche Objekte (12)
Effectiveness of inactivated influenza vaccine against laboratory-confirmed influenza among Chinese elderly: a test-negative design
Comparison of the epidemiology of laboratory-confirmed influenza A and influenza B cases in Manitoba, Canada
Predicting major clinical events among Canadian adults with laboratory-confirmed influenza infection using the influenza severity scale
Pneumonia among adults hospitalized with laboratory-confirmed seasonal influenza virus infection—United States, 2005–2008
Descriptive study of severe hospitalized cases of laboratory-confirmed influenza during five epidemic seasons (2010–2015)
Assessment of two complementary influenza surveillance systems: sentinel primary care influenza-like illness versus severe hospitalized laboratory-confirmed influenza using the moving epidemic method
Effectiveness of influenza vaccine against laboratory-confirmed influenza, in the late 2011–2012 season in Spain, among population targeted for vaccination
Acute cardiac injury events ≤30 days after laboratory-confirmed influenza virus infection among U.S. veterans, 2010–2012
Evaluation of FluSight influenza forecasting in the 2021–22 and 2022–23 seasons with a new target laboratory-confirmed influenza hospitalizations
The temporal distribution of new H7N9 avian influenza infections based on laboratory-confirmed cases in Mainland China, 2013–2017
The burden of laboratory-confirmed influenza infection in Lebanon between 2008 and 2016: a single tertiary care center experience
Laboratory confirmed miltefosine resistant cases of visceral leishmaniasis from India
Effectiveness of inactivated influenza vaccine against laboratory-confirmed influenza among Chinese elderly: a test-negative design
Comparison of the epidemiology of laboratory-confirmed influenza A and influenza B cases in Manitoba, Canada
Predicting major clinical events among Canadian adults with laboratory-confirmed influenza infection using the influenza severity scale
Pneumonia among adults hospitalized with laboratory-confirmed seasonal influenza virus infection—United States, 2005–2008
Descriptive study of severe hospitalized cases of laboratory-confirmed influenza during five epidemic seasons (2010–2015)
Assessment of two complementary influenza surveillance systems: sentinel primary care influenza-like illness versus severe hospitalized laboratory-confirmed influenza using the moving epidemic method
Effectiveness of influenza vaccine against laboratory-confirmed influenza, in the late 2011–2012 season in Spain, among population targeted for vaccination
Acute cardiac injury events ≤30 days after laboratory-confirmed influenza virus infection among U.S. veterans, 2010–2012
Evaluation of FluSight influenza forecasting in the 2021–22 and 2022–23 seasons with a new target laboratory-confirmed influenza hospitalizations
The temporal distribution of new H7N9 avian influenza infections based on laboratory-confirmed cases in Mainland China, 2013–2017
The burden of laboratory-confirmed influenza infection in Lebanon between 2008 and 2016: a single tertiary care center experience
Laboratory confirmed miltefosine resistant cases of visceral leishmaniasis from India
Effectiveness of inactivated influenza vaccine against laboratory-confirmed influenza among Chinese elderly: a test-negative design
Comparison of the epidemiology of laboratory-confirmed influenza A and influenza B cases in Manitoba, Canada
Predicting major clinical events among Canadian adults with laboratory-confirmed influenza infection using the influenza severity scale
Pneumonia among adults hospitalized with laboratory-confirmed seasonal influenza virus infection—United States, 2005–2008
Descriptive study of severe hospitalized cases of laboratory-confirmed influenza during five epidemic seasons (2010–2015)
Assessment of two complementary influenza surveillance systems: sentinel primary care influenza-like illness versus severe hospitalized laboratory-confirmed influenza using the moving epidemic method
Effectiveness of influenza vaccine against laboratory-confirmed influenza, in the late 2011–2012 season in Spain, among population targeted for vaccination
Acute cardiac injury events ≤30 days after laboratory-confirmed influenza virus infection among U.S. veterans, 2010–2012
Evaluation of FluSight influenza forecasting in the 2021–22 and 2022–23 seasons with a new target laboratory-confirmed influenza hospitalizations
The temporal distribution of new H7N9 avian influenza infections based on laboratory-confirmed cases in Mainland China, 2013–2017
The burden of laboratory-confirmed influenza infection in Lebanon between 2008 and 2016: a single tertiary care center experience